Clinical Trials Logo

Neuropathic Pain clinical trials

View clinical trials related to Neuropathic Pain.

Filter by:
  • Completed  
  • Page 1 ·  Next »

NCT ID: NCT06297915 Completed - Neuropathic Pain Clinical Trials

Infusion Treatments of Chronic Peripheral Neuropathic Pain

Start date: May 17, 2022
Phase:
Study type: Observational

This study aimed to evaluate and compare the efficacy of ketamine and lidocaine infusion in patients with chronic peripheral neuropathic pain. Patients who received intravenous ketamine infusion and the other patient group who received intravenous lidocaine infusion were evaluated in the study. Pain scores and quality of life were assessed with scales before treatment at two weeks, two months, and six months after treatment.

NCT ID: NCT06292962 Completed - Diabetes Mellitus Clinical Trials

Evaluating the Impact of Vagus Nerve Stimulation on Diabetic Peripheral Neuropathic Pain

VNSDPN
Start date: October 1, 2023
Phase: N/A
Study type: Interventional

The purpose of the study is to investigate the effects of non-invasive invasive vagal nerve stimulation on diabetic peripheral neuropathic pain in people with diabetes.

NCT ID: NCT06197113 Completed - Neuropathic Pain Clinical Trials

Teta Burst Versus 10 Hz Repetitive Transcranial Magnetic Stimulation İn Neuropathic Pain: A Sham Controlled Comparison

Start date: July 1, 2022
Phase: N/A
Study type: Interventional

Neuropathic pain is a common complication after spinal cord injury (SCI), which significantly affects the patient's quality of life and may be resistant to pharmacological treatment. In our study, we aimed to evaluate the efficacies of intermittent theta burst (iTBS) and high frequency (10 Hz) repetitive transcranial magnetic stimulation (rTMS) by comparing them with each other and with sham stimulation, in the treatment of neuropathic pain resistant to pharmacological treatment in patients with SCI. Question 1: İs rTMS anda iTBS treatment, useful for pain severity and the effect of pain on daily functions, in the treatment of neuropathic pain in SCI Question 2: Are rTMS and iTBS treatments effective in depression in patients with neuropathic pain after spinal cord injury?

NCT ID: NCT05909007 Completed - Chronic Pain Clinical Trials

Post-operative Thoracic Epidural Analgesia and Incidence of Major Complications: a Large Retrospective Dual Center Experi-ence

Start date: April 2012
Phase:
Study type: Observational

A retrospective observational dual center study investigating side effects and major complications after thoracic epidural insertion according to local safety protocols.

NCT ID: NCT05845177 Completed - Opioid Use Clinical Trials

Persistent Pain After Hip Replacement

Start date: September 4, 2023
Phase:
Study type: Observational

This study is a nationwide cross-sectional survey on pain and satisfaction after total hip arthroplasty (THA). Please find the full protocol uploaded on ClinicalTrials.gov

NCT ID: NCT05809700 Completed - Neuropathic Pain Clinical Trials

Injection Therapy for Neuropathic Pain

Start date: June 1, 2023
Phase: N/A
Study type: Interventional

Shoulder, neck, back and temporal pain and herpes zoster pain are neuropathic pain. Preliminary clinical studies have confirmed that injection of freshly prepared HA35 can relieve neuropathic pain. This clinical study is a prospective repeated experiments. The purpose of this study was to verify the effectiveness of HA35 injection therapy.

NCT ID: NCT05802511 Completed - Neuropathic Pain Clinical Trials

Study of Exablate Model 4000 Type 1.0/1.1 Following the Treatment of Neuropathic Pain

Start date: February 1, 2020
Phase: N/A
Study type: Interventional

The Exablate 4000 obtained CE Mark for the treatment of Neuropathic Pain in December 2012. The purpose of this post market study is to obtain real world data on the safety and performance of the Exablate treatment for neuropathic pain. The objective of this study is to capture the change in pain intensity, physical/emotional function, and pain impact for patients diagnosed with neuropathic pain who undergo an Exablate treatment.

NCT ID: NCT05703152 Completed - Clinical trials for Diabetes Mellitus, Type 2

Effect of a Combined Exercise Program on Neuropathic Pain and Perceived Quality of Life in Type 2 Diabetes

Start date: October 31, 2022
Phase: N/A
Study type: Interventional

Therapeutic exercise is one of the therapies used as a treatment for diabetic neuropathy, which is a complication of diabetes. In order to reduce pain and improve the perception of quality of life, a combined therapeutic exercise program will be implemented as an adjuvant and non-pharmacological treatment for diabetic neuropathy.

NCT ID: NCT05687097 Completed - Clinical trials for Spinal Cord Injuries

Untreated Sleep Apnea as an Aggravating Factor for Other Secondary Medical Conditions After Spinal Cord Injury

Start date: September 1, 2020
Phase:
Study type: Observational

This cross-sectional prospective study will assess the potential association of more severe sleep apnea after spinal cord injury with more intense neuropathic pain, more severe spasticity, and more significant cardiovascular abnormalities including cardiac arrhythmias and blood pressure fluctuations. In addition, the participants' experience when undergoing home-based sleep screening test or hospital-unattended sleep screening test will be assessed in a semi-structured interview.

NCT ID: NCT05624853 Completed - Clinical trials for Diabetes Mellitus, Type 2

A Randomized, Active-controlled, Parallel, Open-label, Multicenter, Phase 4 Study to Compare the Efficacy and Safety of Pregabalin Sustained Release Tablet and Pregabalin Immediate Release Capsule in Type II Diabetic Patients With Peripheral Neuropathic Pain

Start date: May 12, 2020
Phase: Phase 4
Study type: Interventional

This study is to compare the efficacy and safety of pregabalin sustained release tablet and pregabalin immediate release capsule in type II diabetic patients with peripheral neuropathic pain.